The use of PARP Inhibitors as Chemoprevention: A vision for the future content
Yorkshire Cancer Research is one of seven leading cancer charities that have come together to explore a bold new frontier in cancer prevention. This joint position statement outlines the potential of PARP inhibitors - drugs already used to treat cancer - as a future option to help prevent cancer in people at high genetic risk. With a shared commitment to innovation, the charities are calling for urgent research to investigate this promising approach.
A vision for the future
The use of PARP Inhibitors as Chemoprevention.
